Text Size
256 studies found for:    Spasticity

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
Spasticity
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Not yet recruiting Reliability of an Algorithm to Diagnose Spasticity
Condition: Spasticity
Intervention:
2 Completed
Has Results 		A Study of the Safety and Effectiveness of Sativex®, for the Relief of Symptoms of Spasticity in Subjects, From Phase B, With Multiple Sclerosis (MS)
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex®;   Drug: Placebo
3 Completed Oral Baclofen Pharmacokinetics and Pharmacodynamics in Children With Spasticity
Conditions: Spasticity;   Cerebral Palsy
Intervention: Drug: baclofen
4 Completed Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant Spasticity
Condition: Muscle Spasticity
Intervention: Drug: Tizanidine (sublingual or oral)
5 Not yet recruiting Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis
Condition: Muscle Spasticity Due to Multiple Sclerosis
Interventions: Drug: BGG492;   Drug: Placebo
6 Withdrawn Continuous Intrathecal Baclofen Infusion for Chronic Spasticity
Condition: Spasticity
Intervention: Device: Prometra Programmable Implantable Pump System
7 Completed Vanderbilt University Spasticity Management Program Evaluation Plan
Condition: Spasticity
Interventions: Drug: Botulinum Toxin Type A;   Drug: Intrathecal baclofen administered by the Medtronic SyncroMed(TM) pump (ITB)
8 Completed Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury
Conditions: Spinal Cord Injury;   Muscle Spasticity
Interventions: Drug: Fampridine-SR;   Other: Placebo
9 Completed Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury
Conditions: Spinal Cord Injury;   Muscle Spasticity
Interventions: Drug: Fampridine-SR;   Drug: Placebo
10 Active, not recruiting A Prospective Study of Spasticity in Individuals With Multiple Sclerosis
Condition: Spasticity
Intervention:
11 Recruiting Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: arbaclofen;   Drug: baclofen;   Drug: Placebo
12 Completed
Has Results 		Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex;   Drug: Placebo
13 Completed Retrospective Study of Patients With Spasticity in the Spanish Population
Condition: Muscle Spasticity
Intervention: Other: No treatment
14 Completed MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity
Condition: Spasticity
Interventions: Drug: Botulinum toxin type A;   Drug: Botulinum Toxin type A
15 Terminated Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury
Condition: Muscle Spasticity
Interventions: Drug: tolperisone HCl (AV650);   Drug: Placebo
16 Completed The Use of Penile Vibratory Stimulation to Decrease Spasticity Following Spinal Cord Injury
Conditions: Spinal Cord Injury;   Muscle Spasticity
Intervention: Procedure: Penile Vibratory Stimulation
17 Terminated Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis
Condition: Muscle Spasticity
Intervention: Drug: tolperisone HCl
18 Completed
Has Results 		A Study of Sativex® for Relief of Spasticity in Subjects With Multiple Sclerosis.
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex®;   Drug: Placebo
19 Recruiting One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity
Conditions: Multiple Sclerosis;   Spasticity
Intervention: Drug: arbaclofen
20 Unknown † Energy Costs of Spasticity in Spinal Cord Injury: A Pilot Investigation
Conditions: Basal Energy Expenditure;   Spasticity
Intervention: Other: Weaning of Antispasticity Medication
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years